9.4K views · 118 reactions | BCRF currently supports 6 researchers focused on developing liquid biopsies – a technology behind a blood test to make diagnosing breast cancer dramatically easier. Watch this video to learn more about this pioneering initiative. | The Breast Cancer Research Foundation | Facebook

Because of you, we hope to make this a landmark year of discoveries. | The Breast Cancer Research Foundation

We’re at SABCS with Dr. Gaorav Gupta, who is offering new insight into a question that has long evaded answers: Can immunotherapy be effective in hormone receptor-positive (HR ) breast cancer? Immunotherapy has had some success in triple-negative breast cancer, but not as much in other subtypes. Dr. Gupta’s study tested whether delivering focused radiation w/pembro prior to surgery could create an immune-stimulating signal that makes immunotherapy more effective for HR /HER2- breast cancers. Ear

At 41, Cherie was diagnosed with Triple Negative Breast Cancer (TNBC) – an aggressive form of the disease. She credits the advances made through previous research for the fact that she is here today. But despite successful treatment, the fear of recurrence remains. She still lives each day wondering if tomorrow her cancer will return. Her hope is simple and powerful: that one day, no one will have to fear dying from breast cancer. Today, on World Cancer Day, we recognise that every experience is

10 new breast cancer treatments have been approved in just the past five years. BCRF-funded researchers are driving incredible progress, but federal funding cuts could put vital cancer research at risk. Help fund the research turning today’s possibilities into tomorrow’s breakthroughs for breast cancer. For a limited time, all gifts are 3X matched. | The Breast Cancer Research Foundation